Viasat’s Deal Repositions to Compete with SpaceX – But is This Reason Enough to Buy VSAT Stock Now?
Viasat, a satellite broadband communications company for the military and commercial markets, enjoyed a 40% boost in stock price Monday morning. This spike resulted from their deal with defense contractor L3 Harris Technologies. In total, the deal is estimated to bring in over $1.8 billion after taxes, fees, and other expenses. The deal will result in Viasat selling its [...]
Nike Stock Falls as Margins Drop & Inventory Grows…Should You Weather the Storm or Sell Now?
Nike stock plunged 12% this morning after another earnings report that missed expectations. While revenue and EPS figures came in strong, the margins slipped up a bit - which has only been exacerbated by inflation. But the real reason analysts and investors alike have growing concern over the trajectory of Nike? Inventory. Their inventory is up 44% - with [...]
A Dwindling Pandemic Spells Disaster for Rite Aid Stock…could it get even worse?
While Rite Aid had a good run during the pandemic, it appears the stock is headed back towards the bottom - as the company reports another quarter of poor results. The retail drug store chain lost over $300 million in the fiscal 2nd quarter. This resulted in a net loss per share of $6.07, way up from the previous [...]
Cheniere Energy Powers Ahead in the Liquefied Natural Gas Market
On Thursday, September 28, LNG had a huge up day with a $10.60 gain (6.95%) after hitting an intraday low of $147.70 on September 26. The high for the year was on September 14 at $178.62. The closing price pierced its 50-day moving average and closed well above it. Over the past year, energy-related stocks have been the leading [...]
What Biogen’s Alzheimer’s Drug Results Means for the Company’s Stock
Yesterday, we discussed how Crispr stock enjoyed a short-lived jump ahead of seeking FDA approval for their gene therapy drug. But today, we’re here to talk about a drug company that has experienced a much larger spike as a result of positive news: Biogen. Biogen is engaged in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. And [...]
Crispr Stock Jumps after Seeking FDA Approval for Gene Therapy Drug…Should You Buy Now?
While many stocks are moving downwards this morning, one stock has made a nice 5% jump since the market opened - and that’s Crispr. The company is engaged in the development of transformative drugs based on gene therapy. And news just released that they are finally on the path to seeking FDA approval for their new drug. But - [...]
